| Name | Title | Contact Details |
|---|
Tucson Medical Center, licensed at 607 beds, has been Tucson`s locally governed nonprofit regional hospital for 70 years. TMC is Southern Arizona`s leading provider for emergency care and pediatric care (including Tucson`s first Pediatric Emergency Department), with top-notch intensive care units for adults, children and newborns. Other specialty areas include women`s, maternity, cardiovascular, orthopaedic, neuroscience, hospice, imaging and senior services. TMC earned certification as a Primary Stroke Center, accreditation as a Chest Pain Center, and the Gold Plus Achievement Award for stroke programs from the American Heart Association/American Stroke Association. TMC is also a recipient of the AHA/ASA`s Target: Stroke Honor Roll. TMC HealthCare is Southern Arizona`s locally governed nonprofit system, the corporate entity that includes Tucson Medical Center and Saguaro Physicians.
CCS Assoc is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Camarillo Health Care District is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Camarillo, CA. To find more information about Camarillo Health Care District, please visit www.camhealth.com
AllMed Healthcare Management is a utilization management and independent review organization providing comprehensive nurse and physician review solutions to payer and provider organizations nationwide. Our clients include leading health plans, medical management organizations, TPAs, disability carriers, hospital groups and ambulatory surgery centers. Services are deployed through PeerPoint, AllMed`s state-of-the-art medical review portal.
Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.